LBI-HTA - Publications - Search - Horizon Scanning in Oncology: Results of the 28th Prioritisation – 3rd quarter 2016

Grössmann, N. and Wild, C. (2016): Horizon Scanning in Oncology: Results of the 28th Prioritisation – 3rd quarter 2016. HSO: 28th Prioritisation.

[img]PDF - Sie müssen einen PDF-Viewer auf Ihrem PC installiert haben wie z. B. GSview, Xpdf oder Adobe Acrobat Reader
432Kb
Abstract

For the 28th prioritisation (September 2016), 9 drugs were filtered out of 283 identified and were sent to prioritisation. Of these, 7 drugs were ranked as 'highly relevant' by the expert panel, 2 as 'relevant' and none as 'not relevant'. For 'highly relevant' drugs, further information including, for example, abstracts of phase III studies and licensing status is contained in this document.

Item Type:DSD: Horizon Scanning in Oncology
Subjects:WB Practice of medicine > WB 300-962 Therapeutics
QZ Pathology > QZ 200-380 Neoplasms.Cysts
QV Pharmacology, toxicology, pharmacy > QV 60-370 Pharmacology
Language:English
Series Name:HSO: 28th Prioritisation
Deposited on:19 Oct 2016 14:26
Last Modified:19 Oct 2016 14:26

Repository Staff Only: item control page